HIMS•benzinga•
Texas Northern Court Ruled Against The Outsourcing Facilities Association's Preliminary Injunction Against The FDA; Pharmacies Categorized Under Section 503A Must Cease The Compounding Of Tirzepatide In Bulk Immediately, And Those Under Section 503B Have
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 6, 2025 by benzinga